Evolve BioSystems, UC Davis baby-probiotic spinout, is going global with new $40M financing


Photo of Evolve BioSystems CEO Tim Brown courtesy of Evolve.
Evolve BioSystems is gearing up to take its infant probiotic global and create new products that fight malnutrition, having scored a $40 million Series C financing led by the Bill and Melinda Gates Foundation and Horizon Ventures, Li Ka Shing Foundation’s venture arm. The ...

Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.

Digital Edition

To read a digital copy of our latest magazine

click here